Technical Analysis for VIVO - Meridian Bioscience Inc.

Grade Last Price % Change Price Change
grade C 16.82 1.20% 0.20
VIVO closed up 1.2 percent on Friday, January 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Jan 24

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical VIVO trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 20 DMA Bullish 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 NR7-2 Range Contraction 0.00%
Jan 17 Fell Below 20 DMA Bearish 1.20%
Jan 17 NR7 Range Contraction 1.20%
Jan 16 Bearish Engulfing Bearish 0.48%
Jan 16 Shooting Star Candlestick Bearish 0.48%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.48%
Jan 16 20 DMA Support Bullish 0.48%
Jan 16 Calm After Storm Range Contraction 0.48%

Older signals for VIVO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.
Is VIVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.84
52 Week Low 13.53
Average Volume 354,313
200-Day Moving Average 15.8889
50-Day Moving Average 17.7626
20-Day Moving Average 16.653
10-Day Moving Average 16.47
Average True Range 0.6147
ADX 24.46
+DI 18.6804
-DI 23.4853
Chandelier Exit (Long, 3 ATRs ) 16.0859
Chandelier Exit (Short, 3 ATRs ) 16.8541
Upper Bollinger Band 17.458
Lower Bollinger Band 15.848
Percent B (%b) 0.6
BandWidth 9.667928
MACD Line -0.245
MACD Signal Line -0.32
MACD Histogram 0.0751
Fundamentals Value
Market Cap 709.86 Million
Num Shares 42.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 33.64
Price-to-Sales 3.13
Price-to-Book 3.70
PEG Ratio 1.29
Dividend 0.50
Dividend Yield 2.97%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.39
Resistance 3 (R3) 17.37 17.16 17.30
Resistance 2 (R2) 17.16 17.01 17.17 17.26
Resistance 1 (R1) 16.99 16.93 17.08 17.01 17.23
Pivot Point 16.78 16.78 16.82 16.79 16.78
Support 1 (S1) 16.61 16.63 16.70 16.63 16.41
Support 2 (S2) 16.40 16.55 16.41 16.38
Support 3 (S3) 16.23 16.40 16.35
Support 4 (S4) 16.25